Companies
Company Logo
Oneliner
Company Logo
Oneliner
Add Entity
snc-logo

Startup Nation Finder

Ecosystem
Startups
Investors
Hubs
Multinationals
Reports toggle reports submenu
My Watchlists
My Saved Searches
Following
Inbox
About Us
Glossary

snackbar-icon
title

Your CSV is on the way

We’ve sent your CSV file to
send file

Provide your business email

To complete this action, please provide your Business email.

Verify your business email

You only need to verify it once.
We’ve sent a verification link to

Create new Watchlist

Watchlist name*
Watchlist must have a valid name.
Description (optional)
Notifications Off
Public content (accessible by all Finder users)

Add to watchlist

    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    The invitation to claim the profile was originally sent to

    or  

    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    Suggest Edits

    Let us know what you think is inaccurate or missing.
    We will check it out and update the profile if needed.

    Claim Profile

    Please provide us the following information. Note that you need to have an email in this organization in order to claim the profile.

    Already have an account? Login

    Verify your email

    We’ve sent a verification link to [email protected]
    Reset password
    Don't have an account? Sign up

    Check your mailbox

    We sent you an email with further instructions to
    [email protected]

    Do not forget to check your spam folder

    Didn’t get the email? Resend email or Contact us

    Password must contain at least 8 characters, one digit, one uppercase and one lowercase letter.

    Save Search

    Search must have a valid name.

    Rename Search

    Search must have a valid name.
    Delete Saved Search Confirmation
    search will be permanently removed from Finder.
    News Analysis
    disclaimer-icon
    Summary generated by AI
    Read article
    Search Startups

    Active, Discovery & Development Startups

    Filters
    Clear

    Search by tag 

    All of
    Any of
    None of

    Sector (1)

    Primary Sector 

    Target Customer 

    Core Technology 

    Funding Stage 

    Founded 

    Total Raised 

    Min
    Max

    Market Cap 

    Min
    Max

    Business Models 

    Product Stage 

    Employees 

    Location 

    Status (1)
    303 Startups 30 In the News 41 Recently Updated
    • Total Funding
      $8.1B
      Raised
      414
      Events
    • Private Funding
      $2.92B
      Raised
      256
      Rounds
    • Public Offerings
      $3.91B
      Raised
      147
      Offerings
    • M&A
      $1.27B
      Raised
      11
      Deals
    Funding
    Number of Employees
    Rounds / Deals
    Funding Stage
    Tags

    There aren’t any companies that match your search
    you can try looking for something else.

    OphtiMed Rx logo

    OphtiMed Rx

    Novel Molecular Treatment for Dry Age-related Macular Degeneration
    2021 B2B 1-10 Seed $1.3M
    pharmaceuticals
    pharma-companies
    drug-discovery
    private-investors
    ophthalmology
    investors
    eye-diseases
    drug-development
    Can-Fite BioPharma logo

    Can-Fite BioPharma

    Public
    Targeted Drugs for Cancer and Inflammatory Diseases
    1994 B2B 11-50 Public $104.45M
    oncology
    cancer
    inflammatory-diseases
    orphan-drug
    pharmaceuticals
    autoimmune-diseases
    biopharmaceutical
    metabolic-disease
    doctors
    drug-discovery
    pharma-companies
    patients
    biotechnology
    drug-development
    hospitals
    VBL Therapeutics logo

    VBL Therapeutics

    Acquired
    Targeted Therapies for Immune-inflammatory Diseases
    2000 B2B 11-50 Public $109.77M
    biotechnology
    inflammatory-diseases
    drug-discovery
    biopharmaceutical
    oncology
    cancer-therapy
    pharma-companies
    cancer
    treatments
    bioconvergence
    Protekt Therapeutics logo

    Protekt Therapeutics

    PKR Inhibition for Treating Neurodegenerative Diseases
    2014 B2B 1-10 Seed $2.25M
    drug-discovery
    pharmaceuticals
    neurology
    alzheimers-disease
    therapeutics
    patients
    amyotrophic-lateral-sclerosis-(als)
    seniors
    neuroscience
    degenerative-diseases
    parkinson
    rare-diseases
    inflammatory-diseases
    Prilenia Therapeutics logo

    Prilenia Therapeutics

    A clinical stage biotechnology company focused on the urgent mission to develop novel therapeutics to slow the progression of neurodegenerative diseases and neurodevelopmental disorders
    2018 B2B 11-50 B $144.5M
    drug-development
    pharmaceuticals
    neurology
    amyotrophic-lateral-sclerosis-(als)
    biotechnology
    parkinson
    degenerative-diseases
    Gilboa Therapeutics logo

    Gilboa Therapeutics

    Next-generation Cell Therapy for the Treatment of Cancer
    2019 B2B, B2C 1-10 Seed Undisclosed
    cells
    treatments
    cancer
    Biokine Therapeutics logo

    Biokine Therapeutics

    Anticancer and Stem Cell Mobilization Drugs
    2000 B2C 1-10 Mature $1.95M
    stem-cells
    biopharmaceutical
    bioprocess
    cancer
    drug-discovery
    doctors
    autoimmune-diseases
    patients
    healthcare-providers

    Notifications settings

    Off
    Frequency:
    Select all

    Search Startups

    303 Results
    Funding Amount
    Funding Stages
    • Total Funding
      $8.1B
      Raised
      414
      Events
    • Private Funding
      $2.92B
      Raised
      256
      Rounds
    • Public Offerings
      $3.91B
      Raised
      147
      Offerings
    • M&A
      $1.27B
      Raised
      11
      Deals

    Funding

    Rounds / Deals

    Funding Stage

    Number of Employees

    There aren’t any companies that match your search
    you can try looking for something else.

    OphtiMed Rx logo
    Raised
    $1.3M
    OphtiMed Rx
    Novel Molecular Treatment for Dry Age-related Macular Degeneration
    Founded:2021
    Business Model:B2B
    Employees:1-10
    Funding Stage:Seed
    Can-Fite BioPharma logo
    Raised
    $104.45M
    Can-Fite BioPharma
    Public
    Targeted Drugs for Cancer and Inflammatory Diseases
    Founded:1994
    Business Model:B2B
    Employees:11-50
    Funding Stage:Public
    VBL Therapeutics logo
    Raised
    $109.77M
    VBL Therapeutics
    Acquired
    Targeted Therapies for Immune-inflammatory Diseases
    Founded:2000
    Business Model:B2B
    Employees:11-50
    Funding Stage:Public
    Protekt Therapeutics logo
    Raised
    $2.25M
    Protekt Therapeutics
    PKR Inhibition for Treating Neurodegenerative Diseases
    Founded:2014
    Business Model:B2B
    Employees:1-10
    Funding Stage:Seed
    Prilenia Therapeutics logo
    Raised
    $144.5M
    Prilenia Therapeutics
    A clinical stage biotechnology company focused on the urgent mission to develop novel therapeutics to slow the progression of neurodegenerative diseases and neurodevelopmental disorders
    Founded:2018
    Business Model:B2B
    Employees:11-50
    Funding Stage:B
    Gilboa Therapeutics logo
    Raised
    Undisclosed
    Gilboa Therapeutics
    Next-generation Cell Therapy for the Treatment of Cancer
    Founded:2019
    Business Model:B2B, B2C
    Employees:1-10
    Funding Stage:Seed
    Biokine Therapeutics logo
    Raised
    $1.95M
    Biokine Therapeutics
    Anticancer and Stem Cell Mobilization Drugs
    Founded:2000
    Business Model:B2C
    Employees:1-10
    Funding Stage:Mature
    Unlock financial data
    Finder is provided for free by the non-profit organization Startup Nation Central.
    • Get unlimited search results
    • Save to custom lists - Watchlists
    • Get notified with news and updates
    • Connect with people
    And much more...
    I already have access,
    I already have access,
    Prev 1 2 3 4 5 6 7 Next
    1 2 3 4 5 6 7
    Prev Next